URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Shreedevi Pandya

Concepts (260)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Muscular Dystrophy, Duchenne
13
2001
51
3.200
Why?
Muscular Dystrophies
23
1981
183
1.680
Why?
Prednisone
12
1981
182
1.610
Why?
Dermatomyositis
1
2011
28
0.800
Why?
Glucocorticoids
2
2009
168
0.760
Why?
Myotonia
3
2007
45
0.740
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2011
93
0.740
Why?
Genetic Vectors
3
1999
349
0.730
Why?
Receptors, Tumor Necrosis Factor
1
2011
146
0.730
Why?
Muscular Dystrophy, Facioscapulohumeral
2
2001
25
0.720
Why?
Severity of Illness Index
6
1996
943
0.700
Why?
Immunoglobulin G
1
2011
494
0.670
Why?
Quality of Life
5
2009
528
0.650
Why?
Genetic Predisposition to Disease
1
2008
317
0.560
Why?
Adolescent
29
1981
5044
0.550
Why?
Myositis, Inclusion Body
2
2008
25
0.530
Why?
Humans
57
1981
37165
0.490
Why?
Simian immunodeficiency virus
2
1999
36
0.480
Why?
Male
44
1981
20139
0.480
Why?
Lentivirus
2
1999
28
0.480
Why?
Mutation
2
2008
1226
0.470
Why?
Young Adult
7
2008
1084
0.470
Why?
Child
26
1983
4342
0.470
Why?
Myotonic Dystrophy
4
1989
208
0.450
Why?
Adult
29
1984
11572
0.430
Why?
Population Surveillance
4
2006
144
0.420
Why?
Voice
1
2011
7
0.410
Why?
Gene Products, rev
1
2001
4
0.410
Why?
Telephone
1
2011
26
0.400
Why?
Spumavirus
1
2001
1
0.400
Why?
Hand Strength
3
2001
34
0.390
Why?
Medical Records
1
2011
140
0.380
Why?
Gene Deletion
3
1996
204
0.380
Why?
HIV-1
3
1999
593
0.380
Why?
Muscle Strength
2
2007
25
0.350
Why?
Double-Blind Method
14
1984
996
0.350
Why?
Middle Aged
19
1989
10013
0.350
Why?
Dose-Response Relationship, Drug
4
1991
1142
0.350
Why?
Child, Preschool
21
1983
2737
0.330
Why?
Pregnenediones
2
2005
7
0.320
Why?
Membrane Glycoproteins
1
2001
376
0.310
Why?
Genotype
3
1996
473
0.310
Why?
Treatment Outcome
7
1997
2671
0.310
Why?
Affect
2
2010
78
0.300
Why?
Female
24
1991
20222
0.300
Why?
Muscles
13
1981
347
0.300
Why?
Drug Administration Schedule
4
1991
374
0.270
Why?
Pilot Projects
5
1997
446
0.270
Why?
Muscle Weakness
2
2007
39
0.250
Why?
Isometric Contraction
3
1994
46
0.250
Why?
Physical Therapy Modalities
3
1985
29
0.250
Why?
Muscle, Skeletal
3
2006
439
0.240
Why?
Shoulder
3
1994
23
0.240
Why?
Muscular Diseases
2
1981
69
0.240
Why?
Caregivers
2
2011
82
0.230
Why?
Cohort Studies
4
2008
984
0.230
Why?
Face
2
1997
48
0.220
Why?
Perception
1
2012
66
0.210
Why?
Exercise Test
1
2012
99
0.210
Why?
Genetic Testing
2
2008
102
0.210
Why?
Neuromuscular Diseases
1
2011
54
0.200
Why?
Complementary Therapies
1
2011
39
0.200
Why?
Health Status Indicators
1
2011
112
0.200
Why?
Neurologic Examination
1
2011
146
0.200
Why?
Treatment Failure
1
2011
131
0.200
Why?
DNA Mutational Analysis
2
2006
192
0.200
Why?
Muscle Contraction
3
1983
176
0.190
Why?
Kaplan-Meier Estimate
1
2011
207
0.190
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2010
17
0.190
Why?
Psychometrics
1
2011
232
0.190
Why?
Point Mutation
2
1996
178
0.190
Why?
Biopsy
2
2006
384
0.190
Why?
Albuterol
2
1998
27
0.180
Why?
Anti-Inflammatory Agents
1
2011
115
0.180
Why?
Healthcare Disparities
1
2011
78
0.180
Why?
Adrenergic beta-Agonists
2
1998
54
0.180
Why?
Insulin-Like Growth Factor I
1
2010
106
0.180
Why?
Adrenal Cortex Hormones
1
2010
99
0.180
Why?
Spinal Muscular Atrophies of Childhood
1
2009
13
0.180
Why?
Palliative Care
1
2011
161
0.170
Why?
Gene Duplication
1
2008
9
0.170
Why?
Dystrophin
1
2008
13
0.170
Why?
Gene Frequency
1
2008
87
0.170
Why?
Genetic Markers
1
2008
132
0.160
Why?
Drug Eruptions
1
2008
29
0.160
Why?
Patient Care Team
1
2009
199
0.160
Why?
Clinical Protocols
2
1994
107
0.160
Why?
Health Knowledge, Attitudes, Practice
1
2011
296
0.160
Why?
Recombinant Proteins
1
2010
770
0.150
Why?
Joints
2
1981
63
0.150
Why?
Disability Evaluation
1
2008
129
0.150
Why?
Software
2
1987
129
0.150
Why?
Nifedipine
1
1987
33
0.150
Why?
Antibodies
1
2008
220
0.150
Why?
Muscular Dystrophies, Limb-Girdle
1
2006
4
0.150
Why?
Extremities
1
1997
36
0.150
Why?
Abstracting and Indexing as Topic
1
2006
10
0.150
Why?
Aged
8
1989
7392
0.150
Why?
Electrodiagnosis
1
2007
50
0.150
Why?
Genes, Dominant
1
1997
82
0.150
Why?
Time Factors
10
1984
3234
0.140
Why?
Risk Assessment
2
2005
875
0.140
Why?
Longitudinal Studies
2
2011
413
0.140
Why?
Data Collection
1
2006
231
0.130
Why?
Action Potentials
1
2007
256
0.130
Why?
Infant
5
1983
2320
0.130
Why?
Creatine Kinase
3
1981
56
0.110
Why?
Clinical Trials as Topic
9
1981
685
0.110
Why?
Arm
2
1997
56
0.110
Why?
Questionnaires
3
2011
1061
0.110
Why?
Pain
2
2000
392
0.100
Why?
Weight Gain
4
1991
56
0.100
Why?
rev Gene Products, Human Immunodeficiency Virus
1
2001
3
0.100
Why?
Oxandrolone
1
2001
4
0.100
Why?
HIV Long Terminal Repeat
1
2001
10
0.100
Why?
DNA, Recombinant
1
2001
41
0.100
Why?
Anabolic Agents
1
2001
16
0.100
Why?
Virus Assembly
1
2001
17
0.100
Why?
Genes, Viral
1
2001
86
0.100
Why?
Response Elements
1
2001
77
0.100
Why?
Follow-Up Studies
5
1985
1889
0.100
Why?
Transgenes
1
2001
75
0.100
Why?
Viral Envelope Proteins
1
2001
86
0.100
Why?
Leprosy
1
2000
6
0.090
Why?
Reproducibility of Results
4
1992
903
0.090
Why?
Nociceptors
1
2000
22
0.090
Why?
Models, Genetic
1
2001
162
0.090
Why?
Muscle Fatigue
1
1999
11
0.090
Why?
Iowa
2
2006
8
0.090
Why?
Cloning, Molecular
1
2001
494
0.090
Why?
Arizona
2
2006
23
0.090
Why?
Colorado
2
2006
15
0.090
Why?
DNA, Viral
1
2001
310
0.090
Why?
Nerve Growth Factors
1
2000
83
0.090
Why?
Viral Proteins
1
2001
214
0.090
Why?
Contracture
4
1983
26
0.080
Why?
Cell Division
1
2001
773
0.080
Why?
Multiple Sclerosis
1
1999
129
0.080
Why?
Activities of Daily Living
2
2008
273
0.080
Why?
Randomized Controlled Trials as Topic
1
2010
415
0.080
Why?
Skin
1
2000
384
0.080
Why?
United States
3
2006
2847
0.070
Why?
Sodium Channels
2
2000
123
0.070
Why?
Transcription, Genetic
1
2001
824
0.070
Why?
Cell Line
1
2001
1623
0.070
Why?
Disease Progression
2
1997
533
0.070
Why?
Random Allocation
4
1987
253
0.070
Why?
Diagnosis, Differential
2
2007
889
0.070
Why?
Computers
2
1981
83
0.060
Why?
New York
2
2006
1378
0.060
Why?
Respiratory Function Tests
3
1987
129
0.060
Why?
Prospective Studies
3
1987
1696
0.060
Why?
Retrospective Studies
2
2009
2302
0.060
Why?
Evaluation Studies as Topic
2
1984
247
0.060
Why?
Azathioprine
1
1993
20
0.060
Why?
Electromyography
3
1987
175
0.050
Why?
Chloride Channels
1
2012
75
0.050
Why?
Georgia
1
2011
15
0.050
Why?
Diagnosis, Computer-Assisted
1
2012
65
0.050
Why?
Qualitative Research
1
2011
56
0.050
Why?
Great Britain
1
2011
100
0.050
Why?
Interview, Psychological
1
2011
78
0.050
Why?
Employment
1
2011
70
0.050
Why?
Family Health
1
2011
93
0.050
Why?
Hispanic Americans
1
2011
105
0.050
Why?
Linear Models
1
2011
248
0.050
Why?
Injections, Subcutaneous
1
2010
93
0.050
Why?
Drug Combinations
1
2010
150
0.050
Why?
Physical Therapy Specialty
1
2009
1
0.050
Why?
Language Disorders
1
2009
15
0.050
Why?
Nutritional Requirements
1
2009
16
0.050
Why?
Respiration Disorders
1
2009
7
0.050
Why?
Gastrointestinal Diseases
1
2009
35
0.050
Why?
Attitude to Health
1
2012
228
0.040
Why?
Exercise Therapy
1
2009
35
0.040
Why?
Aged, 80 and over
2
2006
2588
0.040
Why?
Bone Diseases
1
2009
43
0.040
Why?
European Continental Ancestry Group
1
2011
238
0.040
Why?
Pain Management
1
2009
51
0.040
Why?
Early Diagnosis
1
2009
29
0.040
Why?
African Americans
1
2011
230
0.040
Why?
Penicillamine
1
1988
26
0.040
Why?
Age of Onset
1
2009
126
0.040
Why?
Heart Diseases
1
2009
138
0.040
Why?
Ambulatory Care
1
2009
167
0.040
Why?
Placebo Effect
1
2008
36
0.040
Why?
Internationality
1
2008
28
0.040
Why?
Vitamin E
1
1988
87
0.040
Why?
Testosterone
1
1989
163
0.040
Why?
Muscle Relaxation
1
2007
23
0.040
Why?
Motor Activity
1
2009
186
0.040
Why?
Placebos
2
1993
185
0.040
Why?
Trinucleotide Repeats
1
2007
40
0.040
Why?
Evidence-Based Medicine
1
2009
210
0.040
Why?
Creatinine
2
1981
131
0.040
Why?
Dystroglycans
1
2006
5
0.040
Why?
Needles
1
2007
47
0.040
Why?
Caveolin 1
1
2006
13
0.040
Why?
Body Composition
1
1997
73
0.040
Why?
Leg
1
2007
99
0.040
Why?
Animals
2
1999
16416
0.040
Why?
Organ Size
1
1997
194
0.040
Why?
Chromosomes, Human, Pair 4
1
1996
34
0.040
Why?
Immunophenotyping
1
2006
126
0.040
Why?
Blotting, Southern
1
1996
103
0.040
Why?
Comorbidity
1
2008
377
0.040
Why?
Calpain
1
2006
47
0.040
Why?
Incidence
1
2008
682
0.030
Why?
Muscle Proteins
1
2006
149
0.030
Why?
Time
1
2005
47
0.030
Why?
Predictive Value of Tests
1
2007
609
0.030
Why?
Sensitivity and Specificity
1
2008
914
0.030
Why?
Leucine
1
1984
108
0.030
Why?
Prevalence
1
2006
582
0.030
Why?
Movement
1
1985
168
0.030
Why?
Body Weight
2
1991
337
0.030
Why?
Blotting, Western
1
2006
672
0.030
Why?
Phenotype
1
1996
756
0.030
Why?
Motor Skills
1
1983
45
0.030
Why?
Respiration
1
1983
181
0.030
Why?
Membrane Proteins
1
2006
560
0.030
Why?
Muscle Tonus
1
2001
10
0.030
Why?
Carnitine
1
1981
14
0.020
Why?
Quality Control
1
1981
71
0.020
Why?
Risk Factors
1
2008
2331
0.020
Why?
Body Mass Index
1
2001
229
0.020
Why?
Thiolester Hydrolases
1
2000
7
0.020
Why?
Ubiquitin Thiolesterase
1
2000
14
0.020
Why?
Pain Threshold
1
2000
25
0.020
Why?
Statistics, Nonparametric
1
2001
269
0.020
Why?
Physical Stimulation
1
2000
56
0.020
Why?
Reflex
1
2000
62
0.020
Why?
Drug Therapy, Combination
2
1988
397
0.020
Why?
Vasodilation
1
2000
52
0.020
Why?
Hot Temperature
1
2000
163
0.020
Why?
Keratinocytes
1
2000
103
0.020
Why?
Receptor Protein-Tyrosine Kinases
1
2000
81
0.020
Why?
In Situ Hybridization
1
2000
332
0.020
Why?
Axons
1
2000
193
0.020
Why?
Models, Biological
1
1994
1029
0.020
Why?
Absorptiometry, Photon
1
1998
33
0.020
Why?
Age Factors
1
1981
1152
0.020
Why?
Immunohistochemistry
1
2000
1082
0.020
Why?
Research Design
2
1987
340
0.020
Why?
Biomechanics
1
1994
183
0.010
Why?
Body Height
1
1993
50
0.010
Why?
Pain Measurement
1
1994
248
0.010
Why?
Observer Variation
1
1992
146
0.010
Why?
Wheelchairs
1
1989
5
0.010
Why?
Locomotion
1
1989
28
0.010
Why?
Acne Vulgaris
1
1989
16
0.010
Why?
Cardiomyopathies
1
1989
80
0.010
Why?
Scoliosis
1
1989
50
0.010
Why?
Analysis of Variance
1
1991
749
0.010
Why?
Drug Evaluation
1
1987
99
0.010
Why?
Mice
1
1999
6206
0.010
Why?
Cost-Benefit Analysis
1
1987
215
0.010
Why?
Enzymes
1
1984
28
0.010
Why?
Methods
1
1984
225
0.010
Why?
Methylhistidines
1
1981
12
0.010
Why?

Visualizations


Pandya's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department